Mandate

Vinge has advised Nippon Steel & Sumitomo Metal Corporation in connection with the acquisition of Ovako

March 16, 2018 M&A

Vinge has advised Nippon Steel & Sumitomo Metal Corporation (“Nippon”) on its acquisition of Ovako from Triton. Ovako is a maker of special steel with global top level technology regarding high-cleanliness steel for bearing steel and other such products.

The acquisition of Ovako is a strategic supplement to Nippon’s business concept and will strengthen and expand Nippon’s global business and further strengthen their technology, product quality and product development capabilities for special steels and secure a base of manufacturing and sales in Europe.

Vinge’s team consisted of among others Daniel Rosvall and Ulrich Ziche as well as associates Anna Thoms, Hedvig Ekdahl, Edin Agic, Christina Odengran, Peter Issa, Johan Cederblad, Arvid Axelryd, Lisa Sennerby.

Related

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026